NCT07338838 2026-01-14
To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Not yet recruiting
Clinical Trials
4 trialsNCT06770881 2025-01-13
JSKN033 in Chinese Subjects with Advanced Malignant Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1/2 Not yet recruiting
NCT06691360 2024-11-15
AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors
Akeso
Phase 1 Not yet recruiting
NCT06226363 2024-01-26
Phase I Study of LNF1901 in Advanced Malignant Tumors
Shandong New Time Pharmaceutical Co., LTD
Phase 1 Not yet recruiting